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Considerable  debate  has  centered recently on  the  mechanism(s) by  which 
immune complexes (IC) l lodge in glomerular basement membrane (GBM). The 
traditional  view, namely that soluble  IC  deposit as such from the circulation, 
stemmed from observations that the initiation of glomerulonephritis in experi- 
mental  serum  sickness  coincides  with  the  period  of immune  elimination  of 
antigen, the occurrence of IC in the circulation, and the presence of both antigen 
and antibody in glomeruli (1, 2).  However, the relevance of these observations 
for clinical glomerulonephritis has been challenged for several reasons: there is 
often a  poor correlation between the presence of IC in the circulation and in 
glomeruli, most notably in patients with membranous nephropathy characterized 
by  diffuse  subepithelial  deposits;  soluble  IC  prepared  in  vitro  and  passively 
administered to  experimental animals  tend to  lodge in  the renal  mesangium 
(Mes), and with but few exceptions (3,  4) fail to deposit in the GBM; and 1C 
formation is a dynamic process in which a state of equilibrium between dissociated 
and undissociated IC exists, allowing for the possibility that dissociated antigen 
or antibody could act independently of intact IC  (5).  An alternative view (6), 
namely that IC in GBM result from in situ binding of antibody to structural or 
previously ~planted" antigen, is based on evidence that GBM deposits similar to 
those in human membranous nephropathy can be induced by passive transfer of 
serum from rats with  autologous IC  glomerular disease (Heymann nephritis) 
induced by immunization with tubular epithelial cell brush border antigen (7-9) 
and that similar deposits can result from perfusing the kidney with antibody to 
proximal  tubular  epithelial  cell  brush  border  antigen  under  conditions  that 
essentially exclude circulating IC (10).  Also, in situ complexing of antibody to 
planted antigens bound in the GBM on the basis of electrical charge has been 
demonstrated (1 1). Although the mechanisms by which IC localize in glomeruli 
have often been discussed in "either/or" terms, it should be emphasized that the 
two mechanisms are not mutually exclusive. 
In a  previous study soluble IC, prepared in  vitro from cationic antigen and 
antibody and passively injected into mice, gave rise to GBM deposits (3). The IC 
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in subendothelial and subepithelial sites correlated with the known distribution 
of anionic sites described by others (12,  13) and suggested that cationic IC could 
be trapped  electrostatically on  a  nonimmunological  basis.  Mechanistically,  the 
evidence was consistent with deposition of intact IC from the circulation. How- 
ever, because the cationic antigen by itself could bind to the GBM, the IC had 
been  prepared  in  antigen  excess  to  achieve  solubility,  and  antigen-antibody 
complexes are  to some extent dissociable,  an  in  situ  mechanism  in which  free 
antigen was first deposited with subsequent binding of free antibody, or IC with 
free antibody-combining sites,  could not be entirely excluded (3).  To examine 
directly whether intact, circulating IC per se can cross and deposit in the GBM, 
covalently linked, hence nondissociating, antigen-antibody complexes were used 
in the present study. 
Materials and Methods 
Animals. Male BALB/c AnNCrlBR mice, 6-8-wk old, were obtained from Charles River 
Breeding Laboratories, Inc., Wilmington, MA. 
Antigens and Antisera.  Bovine gamma globulin (BGG; Sigma Chemical Co., St. Louis, 
MO) was further purified by passage through Sephadex G-200 (Pharmacia Fine Chemicals, 
Piscataway, N  J) in phosphate-buffered saline (PBS). The IgG fraction of rabbit anti-BGG 
antiserum  (3)  was  prepared by precipitation in  half-saturated (NH4)2SO4 followed by 
passage through a diethylaminoethyl (DEAE)-cellulose (Schleicher & Schuell, Inc., Keene, 
NH) column in 0.0175 M potassium phosphate, pH 6.3, and gel filtration on Sephadex 
G-200 in PBS. Rhodamine and fluorescein-conjugated IgG fractions of goat anti-rabbit 
IgG, fluorescein-conjugated IgG fraction of rabbit anti-bovine IgG, fluoresceinated goat 
anti-mouse C3 and fluoresceinated goat anti-mouse IgG were obtained from N.L. Cappel 
Laboratories, Cochranville, PA. Affinity-purified and biotinylated goat anti-rabbit IgG 
and  horseradish  peroxidase-avidin-D  were  obtained  from  Vector  Laboratories,  Inc., 
Burlingame, CA. 
Covalent Immune Complexes.  BGG and rabbit anti-BGG were covalently linked in a two- 
stage reaction employing a bifunctional reagent, toluene-2,4-diisocyanate (TDI) (Eastman 
Kodak Co., Rochester, NY), whose groups are activated at different pH (14). BGG (1.5%) 
in 0.05 M potassium phosphate, pH 7.5, was reacted with 2% (vol/vol) TDI for 30 rain 
at room temperature, cooled to 0°C for 15 min, centrifuged at 3,000 g for 15 rain to 
remove solid TDI, passed through a Sephadex G-25 column in 5 mM phosphate, pH 7.5, 
to remove any residual TDI, and left at 0°C for 1 h. To the TDI-activated BGG an equal 
volume and concentration of the IgG fraction of rabbit antiserum to BGG, in the same 
buffer, was added drbpwise with stirring and left for 1 h at 37°C to allow the formation 
of IC.  By quantitative immune precipitation (15)  it was  determined that the  IC were 
prepared in  70-fold antigen excess. To activate the second functional group to induce 
covalent cross-linking between antigen and antibody, the pH was raised to 8.5 by adding 
solid tribasic sodium phosphate.  After  10  min  the pH  was  lowered to  7.5  with  solid 
monobasic sodium phosphate, and the solution was concentrated by ultrafiltration. The 
IC were then applied to a Sepharose 6B column in PBS containing 1 M NaCI to separate 
IC from noncomplexed IgG. The relevant peak was concentrated and then repurified on 
the same Sepharose 6B column. As controls, identical procedures were carried out with 
mixtures of BGG and BGG; anti-BGG and anti-BGG; BGG and normal rabbit gamma 
globulin (RGG). 
For some experiments covalently linked IC were cationized or anionized (3). In other 
experiments BGG was cationized before covalent linkage with unmodified, native anti- 
BGG. 
Analytical Procedures.  SDS-PAGE was performed in vertical slabs, 3% stacking gel, 5% 
running gel, 0.1% SDS (Bio-Rad Laboratories, Richmond, CA) (16).  Agarose (1%) gel 
electrophoresis was  done at  pH  8.6  in  0.06  M  sodium barbital buffer. Sedimentation CAULIN-GLASER ET  AL.  1563 
velocity was performed in a Spinco Model E ultracentrifuge (Beckman Instruments,  Inc., 
Spinco Div., Palo Alto, CA) with ultraviolet optics at a protein concentration of 0.8 mg/ 
ml in PBS. 
Injection Protocol.  Four groups of mice (8-10 mice per group) were sacrificed 1 h after 
tail vein injection with 1 mg of covalently linked IC in 0.4 ml of saline: Group 1, cationic 
IC, chemically modified after covalent coupling; Group 2, cationic IC from chemically 
modified cationic BGG covalently linked to unmodified native rabbit anti-BGG; Group 3, 
native  IC,  both BGG and rabbit  anti-BGG native,  unmodified;  Group 4, anionic  IC, 
chemically modified after covalent coupling. 
Morphology.  Portions of  kidney were processed and examined for immunofluorescence 
and electron microscopy as previously described  (3). For immunoelectron microscopy, 
modifications of previous methods (I 7,  18) were employed. Kidney slices were fixed in 
5% formalin in 0.1  M phosphate,  pH 7.4, for 6 h. After washing in buffer for 3 h, then 
overnight in cold 0.1  M Tris-CI, pH  7.4,  containing  1% bovine serum  albumin  (Tris- 
BSA), the tissue  was soaked  for  30  min  in  0.1  M  Tris-Cl  containing  10%  dimethyl 
sulfoxide, and snap frozen.  Cryostat sections were washed in Tris-BSA, PBS-BSA, and 
suspended in PBS-BSA containing 15 #g/ml biotinylated anti-rabbit  IgG for 2 h. After 
washing in PBS-BSA and 0.1 M NaHCO3-BSA, sections were incubated in NaHCO3-BSA 
containing  50 ~g/ml peroxidase-avidin  for 2 h.  After rinsing and development  of the 
peroxidase reaction,  sections were flat embedded in Epon (17, 18). Glomeruli with cut- 
open loops (to maximize access of reagents) were studied. 
Results 
Covalent Immune Complexes.  As shown previously (14), the method of covalent 
coupling promotes linkage of antigen to antibody, but not self-linkage of antigen 
to antigen or antibody to antibody. This was found to be true in the BGG-anti- 
BGG system as well since the method yielded covalently linked aggregates only 
when antigen and antibody were present  together. The gel filtration pattern 
after the formation of covalent IC is shown in Fig.  1. Complexes demonstrated 
to be separated from nonspecific aggregates and monomeric IgG were used for 
subsequent experiments. On sodium dodecyl sulfate-polyacrylamide  gel electro- 
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FIGURE  1.  Gel filtration through a  50-cm x  1.5-cm column of Sepharose 6B in PBS (1  M 
NaCI) after formation of covalent IC.  Fractions of 1.0 ml were collected. Molecular weight 
standards were blue dextran (BD), a  human IgM myeloma protein, and BGG. The fraction 
indicated by the double-headed arrow, tubes 20-32, was repassed through the same column 
and used for subsequent experiments. 1564  COVALENT  IMMUNE  COMPLEXES  DEPOSITING IN  GLOMERULI 
FIGURE  2.  SDS-PAGE of purified covalent,  unreduced IC (lane 3),  that fail to enter the 
running gel. Lane 1 contains standards:  human secretory IgA, BGG, and F(ab')~ fragment of 
rabbit IgG. Lane 2 has a control mixture of BGG and normal RGG (instead of rabbit antibody 
to BGG) treated in the same  way as the IC; the IgG is predominantly monomeric, and all 
protein enters the running gel.  Other controls of BGG plus  BGG or rabbit anti-BGG  plus 
rabbit anti-BGG gave the same pattern as lane 2. 
FIGURE 3.  Characterization  of covalent  1C by double immunodiffusion  in agarose gel. The 
center well on the left contains  IC and the top wells contain goat anti-BGG and goat anti- 
RGG. The center well on the right contains  a control mixture of BGG and normal RGG 
treated in the same manner as the IC. The continuous precipitation  line in the left pattern 
indicates that the BGG and RGG are linked  together; compare with the double spur in the 
control (right pattern). 
phoresis  (SDS-PAGE) (Fig.  2),  the purified  IC in  lane  3  were too large  to enter 
the running  gel,  and  were not contaminated  with  unbound  or dissociable  mon- 
omeric IgG or small aggregates.  In contrast, the protein in control mixtures such 
as BGG and normal  RGG (lane  2),  which had been  treated  in the same manner 
as  the  IC,  did  not  form  large  aggregates  and  therefore  wholly  entered  the 
running gel. The  fact that the IC did not dissociate in the presence of detergent 
confirms their covalent nature. 
As demonstrated  by a  continuous precipitation  line after  double  immunodif- 
fusion in gel,  the covalent complexes contained both BGG and rabbit anti-BGG 
linked together (Fig.  3). 
The  covalent  IC  that  formed  between  cationic  antigen  and  native  antibody 
and were purified by gel filtration  were analyzed by sedimentation  velocity. The 
complexes were broadly heterogeneous,  as would be expected,  with an average 
s20,w =  28S. CAULIN-GLASER ET  AL.  1565 
FmVRE 4.  Agarose gel electrophoresis, pH 8.6, after Coomassie Blue staining to show the 
relative mobilities  of the different covalent complexes. Well 1  : cationic complexes, modified 
after covalent  binding; well  2: cationic BGG-native  anti-BGG, BGG chemically  modified before 
covalent binding to rabbit anti-BGG; well 3: native BGG-native  anti-BGG complexes; well 4: 
anionic complexes, modified after covalent binding. 
Appropriate  chemical  modification  of  the  covalently  linked  IC  produced 
distinctly cationic or anionic complexes as shown by their migration  in agarose 
gel electrophoresis (Fig.  4, top and bottom). Cationization  of the BGG before 
covalent linkage with native unmodified rabbit anti-BGG also resulted in cationic 
IC,  well 2,  but with a  lower net charge  than  complexes in which both antigen 
and antibody were cationized. 
Renal Morphology.  After intravenous  injection,  the two types of cationic  IC 
(those  with  antigen  and  antibody  both  modified,  or  those  with  only antigen 
modified)  deposited  di~ffusely  and  uniformly  in  the  GBM  of  the  peripheral 
capillary walls, since both BGG and RGG were detected in the same distribution 
by immunofluorescence (Fig. 5 and Table I). There was some variability in the 
intensity  of staining  among  animals,  but no consistent difference between the FIGURE 5.  Immunofluorescence  for  BGG  (left)  and  RGG  (right).  Glomeruli  from  mice 
receiving covalent IC containing cationic BGG and cationic anti-BGG, group 1 (A and B), or 
cationic BGG and native anti-BGG, group 2 (C and D), demonstrate codeposition of antigen 
and antibody in peripheral capillary loops. In contrast, glomeruli from mice given covalent IC 
prepared  from native BGG and  native anti-BGG, group  3  (E and F),  or anionic BGG and 
anionic anti-BGG, group 4 (G and H), show deposits in Mes but none in peripheral loops,  x 
300. 
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TABLE  I 
Glomerular Localization of Intravenously Injected Covalent Immune Complexes 
1567 
Immune reactants*  Ultrastructural deposits* 
Suben  o 
IC Group*  No. of  BGG  RGG  No. of  Subep-  dothe-  Mesan- 
mice  mice  ithelial  lial  gial 
1--Cationic  10  1-3+ GBM  1-3+ GBM  9  1-2+  1-3+  1  + 
2--Cationic BGG/Native  10  1-3+ GBM  1-3+ GBM  5  1-2+  1-3+  1+ 
Anti-BGG 
3--Native  8  1+ Mes  1+ Mes  2  0  0  2+ 
4--Anionic  10  0-1+ Mes  0-1+ Mes  7  0  0  0-2+ 
* In groups 1 and 4, cationization and anionization were done after covalent complex formation. In 
group 2,  the BGG antigen was cationized before IC formation; the rabbit antibody to BGG was 
unmodified. In group 3, both antigen and antibody were unmodified. 
* The variability of intensity of immunofluorescent staining and number and size of ultrastructural 
deposits are given as a range on a scale of 0 to 3+. In group 4, half the mice showed no detectable 
antigen or antibody. 
two cationic groups. Ultrastructurally, in both cationic groups there were discrete 
deposits diffusely in the subepithelial and subendothelial layers of the GBM (Fig. 
6  and Table  I).  There was variation in  size and number of deposits in  loops 
within the same glomerulus; in some loops the deposits were of similar size and 
number in both layers while in other loops the deposits were larger and more 
numerous  in  the  subendothelial  than  in  the  subepithelial  layer.  The  latter 
difference was observed more frequently in group 2 than in group 1. Occasionally 
deposits  were  seen  in  the  lamina  densa.  Small  deposits  were present  in  the 
mesangial matrix along the luminal front and at the junction of the mesangium 
and capillary wall in both cationic groups. 
In mice given unmodified or anionic covalent IC (groups 3 and 4), the findings 
differed from those given cationic IC  in that none showed GBM  deposits.  By 
immunofluorescence microscopy both BGG and RGG, restricted to the mesan- 
gium, were found in all of the mice in group 3 (native IC) and in half the mice 
in group 4 (anionic IC). Ultrastructurally, electron-dense deposits were present 
within the mesangial matrix but not in the GBM. 
The immunoelectron microscopic studies confirmed the other observations in 
that both cationic groups, but not the native, anionic or control groups, had the 
enzyme reaction product marking the site of RGG antibody in the GBM (Fig. 
7). It should be especially noted that even group 2 complexes containing native 
antibody were able to penetrate to the subepithelial layer. RGG was detected 
not only in subepithelial and subendothelial layers, but also in the lamina densa, 
which by ordinary electron microscopy has a  greater density than the laminae 
rarae, thus obscuring less dense small IC. 
None of the mice in any group showed staining for mouse C3;  mouse IgG, 
present in the mesangium in background amounts, was similar in all groups. 
Discussion 
Our previous study showed that injected preformed soluble cationic, but not 
anionic, IC can give rise to  GBM  deposits in subendothelial and subepithelial F
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FIGURE 7.  Immunoelectron micrographs  of peripheral GBM of glomeruli incubated with 
biotinylated anti-RGG and peroxidase-avidin.  In mice given covalent IC containing cationic 
BGG and native anti-BGG, group 2, RGG antibody labeled by the black enzymatic reaction 
product is present in all layers of the GBM (A). Reaction product is absent from the GBM of 
mice given covalent  IC containing native BGG and native anti-BGG, group 3 (B)'and from 
controls given cationic BGG and normal RGG (C). Unstained sections. × 78,000. 1570  COVALENT  IMMUNE  COMPLEXES  DEPOSITING  IN  GLOMERULI 
sites and emphasized the potential importance of charge as a determinant of IC 
localization (3). Exploiting this tendency of cationic IC to deposit in GBM, in the 
present  work  we  used  soluble,  but  nondissociating  complexes  to  determine 
whether IC in the circulation can cross the GBM as intact complexes and deposit 
in subepithelial sites, a point that has been difficult to establish in passive serum 
sickness and which has led in part to doubts of the importance of circulating IC 
in common forms of clinical glomerulonephritis. The complexes with the ability 
to localize along both aspects of the GBM contained BGG antigen and rabbit 
anti-BGG antibody covalently linked together, as indicated by SDS-PAGE and 
double immunodiffusion, were large (average sedimentation coefficient of 28S), 
and had a  net positive charge as shown in agarose gel electrophoresis, which 
minimizes electroendosmosis. Accordingly, conditions required for in  situ  IC 
formation in the GBM, as initiated by planted or intrinsic antigen, were essentially 
eliminated. The observation that relatively large, covalent, cationic IC were able 
to lodge in the GBM strongly suggests that intact IC, under appropriate condi- 
tions, have the potential to cross the GBM and deposit in subepithelial sites, and 
are not necessarily excluded by size alone. Such a mechanism is fully consistent 
with the traditional concept of glomerular IC formation in active serum sickness, 
where glomerular lesions were found predominantly in animals forming large 
IC, greater than 19S in size (19, 20). 
Evidence that parallel exclusion of IC can occur on the basis of charge derives 
from the observation that covalently linked IC with a  negative charge did not 
deposit in the GBM.  This result supports our previous conclusions concerning 
the potential importance of IC charge in the formation of GBM deposits (3). 
While  the  evidence presented  clearly demonstrates  that  intact,  sufficiently 
cationic IC can directly deposit in the GBM from the circulation, it should be 
pointed out that the significance of the current and related findings for human 
glomerulonephritis remains to be established. Nevertheless, it is well known that 
the immune response is usually heterogeneous with respect to the charge of the 
antibodies  formed,  and  natural  antigens  can  likewise  vary  in  charge.  Thus, 
conceptually it  is plausible  that  in  a  situation  where IC  of widely diverse net 
charges are circulating, those complexes on the very cationic end of the spectrum, 
which may be but a small fraction of the total, could be the ones that lodge in 
the giomerulus and cause disease. In the present study the group 2 IC composed 
of cationized antigen and native antibody could be especially relevant. 
Summary 
The  mechanisms  by  which  immune  complexes  deposit  in  the  glomerular 
basement membrane have been the subject of much debate, with the relative 
importance of direct deposition of circulating immune complexes (IC) vs.  for- 
mation of IC  in situ  from the binding of circulating antibody to structural or 
exogenous planted antigen being at issue. In order to determine whether intact 
IC can deposit as such, covalently linked IC were prepared by a two-step reaction 
involving the bifunctionai reagent toluene-2,4-diisocyanate (TDI),  the antigen 
bovine  gamma  globulin  (BGG),  and  rabbit  anti-BGG  antibody.  Antigen and 
antibody were covalently cross-linked, with little self-linkage of antigen or anti- 
body, and IC were purified by gel filtration. The net charge of the complexes CAUL1N-GLASER ET  AL.  1571 
was varied by chemical means, either before or after IC formation. When cationic 
IC were injected intravenously into mice, there was codeposition of antigen and 
antibody diffusely in the glomerular basement membrane (GBM), and deposits 
were observed ultrastructurally in the laminae rarae,  interna and externa, and 
the lamina densa. Thus, under conditions of restricted appropriate charge, intact 
IC can cross the glomerular basement membrane and deposit in  subepithelial 
sites without being excluded by size alone. 
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